Personalized Circulating Tumor DNA Analysis for Predicting Outcomes and Tracking Response to Radiotherapy and Pembrolizumab in Localized Sarcomas: Analysis of the SU2C-SARC032 Trial Women with stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results